2Tweleves C. Capecitabine as first-line in treat colorectal cancer;poold data from two large phase 3 trials[J]. European Journal of Cancer. 2002,38(2) :15-20.
3Fellu J, Escudero P, Losa F, et al. A study of capecitabine in elderly patients as first-line treatment in advanced or metastatic colorectal cancer [ J ]. EJC, 2003,5 ( 1 ) :81.
4K. Sumpter, C. Harper-Wynne, D. Cunningham, et al. Oxalipliatin and capecitabine chemotherapy for advanced or metastatic colorectal cancer;asingle institution' s experience[j]. Clinical Oncology,2003,15(5) :221-226.
5Sawada N, Tanaka Y, Twelves C. et al. Capecitabine puls oxalipliatin ; findings from a human colon cancer xcnograft model and a phase 2 clinical trial in patients with metastatic colorcctal cancer[J]. EJC, 2003,1(5):93.
6Cassidy J, Twelves C, Tabemero J, et al. Capecitabine puls oxalipliatin active as first-line therapy for patients with metastatic colorectal cancer[J]. J Clin Oncol, 2004,22( 11 ) :2084-2091.
7Part YZ, Leibman J, Diamandidis D, et al. Capecitabine puls irinotecan in first-line metastatic colorectal cancer; update on a phase 2 trial[J]. EJC, 2003,1(5) :93.
8Lira DH, Park YS, Park BB, et al. Mitomycin-c and capecitabine as third-line chemotherapy in patients with metastatic colorectal cancer.;a phase 2 study [ J ]. Cancer Chemother Pharmacol,2005,3:22.
9Raos, Cunningham. D, Price T, et al. Phase 2 study of capecitabine and mitomycin-c as first-line treatment in patients with advanced colorectal cancer[ J ]. Br J Cancer, 2004,91 (5) :839-843.
10Eleftheriadies N, Pisterou-Gombaki K, Kouloulias V, et al.Capecitabine use as radiosensitizer during palliatire radiotherapy for advanced or metastatic colorectal cancer[J]. European Journal of Internal Medicine,2003,14(1):56.
